Multiple Sclerosis: Pathogenesis Mechanism and Biomarkers.

Area of Science:

• Neurology
• Neuroimmunology
• Neurodegeneration

Background:

• Multiple sclerosis (MS) is a chronic, inflammatory, and neurodegenerative disease of the Central Nervous System (CNS).
• It is characterized by neurological symptom fluctuations and progressive disability.
• The exact etiology of MS remains undefined, necessitating further research into its pathophysiology.

Purpose of the Study:

• To provide a concise overview of MS disease activity, progression, and pathogenesis.
• To emphasize the role of biomarkers in MS as potential therapeutic targets.
• To identify novel therapeutic interventions for MS.

Main Methods:

• A comprehensive literature survey was conducted using major scientific websites and search engines.
• Key research papers and reviews on MS pathogenesis and biomarkers were analyzed.
• Information on pathological hallmarks and therapeutically valuable biomarkers was synthesized.

Main Results:

• Pathological hallmarks of MS include cortical inflammation, neurodegeneration, demyelination, axonal injury/loss, and glial activation.
• Numerous biomarkers such as CNS neurofilaments, GFAP, CXCL13, and miRNAs are identified.
• These biomarkers are crucial for understanding disease mechanisms and developing targeted therapies.

Conclusions:

• Understanding MS pathophysiology and identifying specific biomarkers are critical for therapeutic intervention.
• Biomarkers can aid in identifying at-risk individuals and improving treatment efficacy for progressive MS.
• Further research into MS biomarkers holds promise for advancing treatment strategies and patient outcomes.